SCHEMBL30879093

SCHEMBL30879093

CSc1ncc(C(=O)O)c(NC2CCC(NC(=O)OC(C)(C)C)CC2)n1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MERTK Q12866 2/20 0.47
▸ BTK Q06187 6/20 0.44
▸ CKS1B P61024 1/20 0.42
▸ SKP1 P63208 1/20 0.42
▸ SKP2 Q13309 1/20 0.42
▸ PDE4B Q07343 1/20 0.42
▸ SYK P43405 2/20 0.41
▸ JAK1 P23458 5/20 0.41
▸ KDM1A O60341 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ PPARG P37231 1/20 0.39
▸ JAK2 O60674 2/20 0.39
▸ TYK2 P29597 1/20 0.38
▸ JAK3 P52333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879016 0.87 ALDH1A1 (0.52) MERTKBTKSYK
SCHEMBL16415194 0.87 MERTK (0.41) MERTKBTKCKS1BSKP1SKP2
SCHEMBL15249748 0.86 SYK (0.51) MERTKPDE4BSYKPPARG
SCHEMBL16202740 0.85 MERTK (0.49) MERTKBTKCKS1BSKP1SKP2
SCHEMBL30878946 0.85 MERTK (0.46) MERTKBTKCKS1BSKP1SKP2
SCHEMBL26931042 0.82 MERTK (0.57) MERTKSYKPPARG
SCHEMBL26931049 0.82 MERTK (0.57) MERTKSYKPPARG
SCHEMBL16415196 0.82 PDE4B (0.39) MERTKBTKCKS1BSKP1SKP2
SCHEMBL1226594 0.81 MEN1 (0.49) MERTKSYKPPARG
SCHEMBL26161013 0.81 SYK (0.49) MERTKSYKPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 — — EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 — — WO disclosed
Send feedback